Signos Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20M

  • Investors
  • 20

Signos General Information

Description

Developer of a weight loss application designed to recommend meals and exercises that transform the weight loss journey. The company's application offers continuous tracking with a wearable glucose sensor, personalized insights from logged meals and daily activities, and interactive guidance, enabling adults focused on weight management to make informed choices about food and movement that support improved metabolic health.

Contact Information

Website
www.signos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2625 Middlefield Road
  • Suite 720
  • Palo Alto, CA 94306
  • United States
+1 (650)
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Technology Systems
Application Software
Monitoring Equipment
Corporate Office
  • 2625 Middlefield Road
  • Suite 720
  • Palo Alto, CA 94306
  • United States
+1 (650)

Signos Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Signos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 27-May-2026 $20M Completed Generating Revenue
3. Later Stage VC (Series B) 20-Jun-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Nov-2021 $13M $17M Completed Generating Revenue
1. Seed Round 30-Dec-2020 $4M $4M Completed Generating Revenue
To view Signos’s complete valuation and funding history, request access »

Signos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
FF Preferred
Series A
Seed-1 5,372,009 $0.000100 $0.37 $0.37 1x $0.37 9.11%
Seed 7,385,487 $0.000100 $0.27 $0.27 1x $0.27 12.52%
To view Signos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Signos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a weight loss application designed to recommend meals and exercises that transform the weight loss journey.
Clinics/Outpatient Services
Palo Alto, CA
45 As of 2023

Wilmington, DE
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Signos Competitors (10)

One of Signos’s 10 competitors is Nutrisense, a Formerly VC-backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nutrisense Formerly VC-backed Wilmington, DE
GlySens Venture Capital-Backed San Diego, CA
Welldoc Venture Capital-Backed Columbia, MD
MySugr Formerly VC-backed Vienna, Austria
Levels Venture Capital-Backed New York, NY
You’re viewing 5 of 10 competitors. Get the full list »

Signos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Signos Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
450 Ventures Corporate Venture Capital Minority
Blue Cross Blue Shield of Alabama Corporation Minority
DexCom Corporation Minority
CB3 Holdings Venture Capital Minority
Cheyenne Partners Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Signos FAQs

  • When was Signos founded?

    Signos was founded in 2018.

  • Where is Signos headquartered?

    Signos is headquartered in Palo Alto, CA.

  • What is the size of Signos?

    Signos has 45 total employees.

  • What industry is Signos in?

    Signos’s primary industry is Clinics/Outpatient Services.

  • Is Signos a private or public company?

    Signos is a Private company.

  • What is Signos’s current revenue?

    The current revenue for Signos is .

  • How much funding has Signos raised over time?

    Signos has raised $57M.

  • Who are Signos’s investors?

    450 Ventures, Blue Cross Blue Shield of Alabama, DexCom, CB3 Holdings, and Cheyenne Partners are 5 of 20 investors who have invested in Signos.

  • Who are Signos’s competitors?

    Nutrisense, GlySens, Welldoc, MySugr, and Levels are some of the 10 competitors of Signos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process